IT posts strong second-quarter 2025 with EPS up 18.5% and revenues rising 5.6% y/y, but trims its full-year revenue and EBITDA guidance.

IT posts strong second-quarter 2025 with EPS up 18.5% and revenues rising 5.6% y/y, but trims its full-year revenue and EBITDA guidance.

MO beats second-quarter estimates with strong oral tobacco gains and trims FY25 EPS outlook amid shifting tobacco market trends.

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

VRSK posts 8.1% y/y EPS growth in second-quarter 2025, and lifts its revenue and EBITDA guidance despite a lowered EPS outlook.

VRSK posts 8.1% y/y EPS growth in second-quarter 2025, and lifts its revenue and EBITDA guidance despite a lowered EPS outlook.

SW misses Q2 EPS estimates despite surging sales and EBITDA growth across all regions post-merger.

SW misses Q2 EPS estimates despite surging sales and EBITDA growth across all regions post-merger.

FTV misses Q2 EPS estimates but beats on revenue. It completes the Ralliant spin-off and reaffirms full-year earnings guidance.